ANTI-HSP60 and ANTI-HSP70 antibody levels and micro/ macrovascular complications in type 1 diabetes: The EURODIAB Study

Journal of Internal Medicine

Volumn 266, Issue 6, 2009, Pages 527-536

  Gruden, G ^a   Bruno, G ^a   Chaturvedi, N ^b   Burt, D ^a   Pinach, S ^a   Schalkwijk, C ^c   Stehouwer, C D ^c   Witte, D R ^d   Fuller, J H ^d   Cavallo Perin, P ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Atherosclerosis; Epidemiology; HSP60; HSP70; Microcirculation; Type 1 diabetes mellitus

Indexed keywords

ALBUMIN; HEAT SHOCK PROTEIN 60; HEAT SHOCK PROTEIN 60 ANTIBODY; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70 ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ACHILLES REFLEX; ADOLESCENT; ADULT; ALBUMIN BLOOD LEVEL; ANGINA PECTORIS; ANTIBODY BLOOD LEVEL; AREFLEXIA; ARTICLE; AUTONOMIC NEUROPATHY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CROSS-SECTIONAL STUDY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART INFARCTION; HUMAN; IMMUNE RESPONSE; INSULIN DEPENDENT DIABETES MELLITUS; KNEE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; MICROANGIOPATHY; PRIORITY JOURNAL; STROKE; VASCULAR DISEASE;

ADOLESCENT; ADULT; ANTIBODIES; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHAPERONIN 60; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; RISK FACTORS; YOUNG ADULT;

EID: 70449334189     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2009.02129.x     Document Type: Article

References (35)

1. Ellis RJ, van der Vies SM. Molecular chaperones. Annu Rev Biochem 1991 60 : 321 347.
2. Feder ME, Hofmann GE. Heat-shock proteins, molecular chaperones, and the stress response: evolutionary and ecological physiology. Annu Rev Physiol 1999 61 : 243 282.
3. Pockley AG. Heat shock proteins, inflammation, and cardiovascular disease. Circulation 2002 105 : 1012 1027.
4. Macario AJ, Conway de Macario E. Sick chaperones, cellular stress, and disease. N Engl J Med 2005 353 : 1489 1501.
5. van Eden W, van der Zee R, Prakken B. Heat-shock proteins induce T-cell regulation of chronic inflammation. Nat Rev Immunol 2005 5 : 318 330.
6. Schett G, Xu Q, Amberger A et al. Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest 1995 96 : 2569 2577.
7. Van Eden W, Wick G, Albani S, Cohen I. Stress, heat shock proteins, and autoimmunity: how immune responses to heat shock proteins are to be used for the control of chronic inflammatory diseases. Ann N Y Acad Sci 2007 1113 : 217 237.
8. Zhu J, Quyyumi AA, Rott D et al. Antibodies to human heat-shock protein 60 are associated with the presence and severity of coronary artery disease: evidence for an autoimmune component of atherogenesis. Circulation 2001 103 : 1071 1075.
9. Pockley AG, Georgiades A, Thulin T, de Faire U, Frostegård J. Serum heat shock protein 70 levels predict the development of atherosclerosis in subjects with established hypertension. Hypertension 2003 42 : 235 238.
10. Zhu J, Quyyumi AA, Wu H et al. Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler Thromb Vasc Biol 2003 23 : 1055 1059.
11. Gruden G, Bruno G, Chaturvedi N et al. Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study: a novel circulating marker for diabetic neuropathy. Diabetes 2008 57 : 1966 1970.
12. The EURODIAB IDDM Complications Study Group. Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia 1994 3 : 278 285.
13. Chaturvedi N, Sjoelie AK, Porta M et al. EURODIAB Prospective Complications Study et al. Markers of insulin resistance are strong risk factors for retinopathy incidence in type 1 diabetes. Diabetes Care 2001 24 : 284 289.
14. Chaturvedi N, Schalkwijk CG, Abrahamian H, Fuller JH, Stehouwer CD, EURODIAB Prospective Complications Study Group. Circulating and urinary transforming growth factor beta1, Amadori albumin, and complications of type 1 diabetes: the EURODIAB prospective complications study. Diabetes Care 2002 25 : 2320 2327.
15. Schram MT, Chaturvedi N, Schalkwijk C et al. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care 2003 26 : 2165 2173.
16. Schram MT, Schalkwijk CG, Bootsma AH et al. Advanced glycation end products are associated with pulse pressure in type 1 diabetes: the EURODIAB Prospective Complications Study. Hypertension 2005 46 : 232 237.
17. Schram MT, Chaturvedi N, Schalkwijk CG, Fuller JH, Stehouwer CD, EURODIAB Prospective Complications Study Group. Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetologia 2005 48 : 370 378.
18. Aldington SJ, Kohner EM, Meuer S, Klein R, Sjolie A-K, the EURODIAB IDDM Complications Study Group. Methodology for retinal photography and assessment of diabetic retinopathy: the EURODIAB IDDM Complications Study. Diabetologia 1995 38 : 437 444.
19. Shipchandler MT, Moore EG. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMx analyzer. Clin Chem 1995 41 : 991 994.
20. Rothman KJ, Greenland S. Modern Epidemiology, 2nd edn. Philadelphia, PA : Lippincott Williams & Wilkins, 1998.
21. Johnson AD, Berberian PA, Bond MG. Effect of heat shock proteins on survival of isolated aortic cells from normal and atherosclerotic cynomolgus macaques. Atherosclerosis 1990 84 : 111 119.
22. Herz I, Rosso R, Roth A, Keren G, George J. Serum levels of anti heat shock protein 70 antibodies in patients with stable and unstable angina pectoris. Acute Card Care 2006 8 : 46 50.
23. Kiechl S, Egger G, Mayr M et al. Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study. Circulation 2001 103 : 1064 1070.
24. Xu Q, Schett G, Perschinka H et al. Serum soluble heat shock protein 60 is elevated in subjects with atherosclerosis in a general population. Circulation 2000 102 : 14 20.
25. Soltys BJ, Gupta RS. Cell surface localization of the 60 kDa heat shock chaperonin protein (hsp60) in mammalian cells. Cell Biol Int 1997 21 : 315 320.
26. Ozawa Y, Kasuga A, Nomaguchi H et al. Detection of autoantibodies to the pancreatic islet heat shock protein 60 in insulin-dependent diabetes mellitus. J Autoimmun 1996 9 : 517 524.
27. van Halm VP, Slot MC, Nurmohamed MT, Cohen Tervaert JW, Dijkmans BA, Voskuyl AE. Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis 2006 65 : 590 594.
28. Xiao Q, Mandal K, Schett G et al. Association of serum-soluble heat shock protein 60 with carotid atherosclerosis: clinical significance determined in a follow-up study. Stroke 2005 36 : 2571 2576.
29. Giannessi D, Colotti C, Maltinti M et al. Circulating heat shock proteins and inflammatory markers in patients with idiopathic left ventricular dysfunction: their relationships with myocardial and microvascular impairment. Cell Stress Chaperones 2007 12 : 265 274.
30. Dhingra R, Larson MG, Benjamin EJ et al. Cross-Sectional correlates of serum heat shock protein 70 in the community. Am J Hypertens 2006 19 : 227 231.
31. Genth-Zotz S, Bolger AP, Kalra PR et al. Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival. Int J Cardiol 2004 96 : 397 401.
32. Rea IM, McNerlan S, Pockley AG. Serum heat shock protein and anti-heat shock protein antibody levels in aging. Exp Gerontol 2001 36 : 341 352.
33. Njemini R, Lambert M, Demanet C, Kooijman R, Mets T. Basal and infection-induced levels of heat shock proteins in human aging. Biogerontology 2007 8 : 353 364.
34. Chen HS, Jia J, Su HF et al. Downregulation of the constitutively expressed Hsc70 in diabetic myocardium is mediated by insulin deficiency. J Endocrinol 2006 190 : 433 440.
35. Finotti P, Pagetta A. A heat shock protein70 fusion protein with alpha1-antitrypsin in plasma of type 1 diabetic subjects. Biochem Biophys Res Commun 2004 315 : 297 305.